# Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate

> **NCT00040456** · PHASE2 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 12 (actual)

## Conditions studied

- HEMOGLOBIN SC DISEASE

## Interventions

- **DRUG:** Mg Pidolate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00040456
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2012-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040456, "Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00040456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*